This is the highest authority in the Institute, with supervisory powers. Its responsibilities include changes to SIB’s statutes, the nomination of Group Leaders, and the approval of the annual budget and financial report. SIB’s partner institutions are represented in this Council.

President

  • Prof. Felix Gutzwiller, Former Senator.

Founding members

  • Prof. Ron Appel, SIB Executive Director, Professor at the University of Geneva;
  • Prof. Amos Bairoch, Group Leader, SIB and University of Geneva;
  • Dr Philipp Bucher, Group Leader, SIB and EPFL;
  • Prof. Denis Hochstrasser, Vice-Rector, University of Geneva, Head of Genetic and Laboratory Medicine Department, Geneva University Hospital (HUG);
  • Prof. C. Victor Jongeneel, Carl R. Woese Institute for Genomic Biology, University of Illinois, USA;
  • Prof. Manuel Peitsch, Chairman, SIB Board of Directors and Chief Scientific Officer Research at Philip Morris International.

Ex officio members

  • Dr Claire Baribaud, Director, School of Business Administration (HEG-Geneva), HES-SO;
  • Prof. Henri Bounameaux, Dean, Faculty of Medicine, University of Geneva;
  • Prof. Edouard Bugnion, Vice-President for Information Systems, EPFL;
  • Prof. François Bussy, Vice Rector for Research, International Relations and Continuing Education, University of Lausanne;
  • Prof. Daniel Candinas, Vice-rector Research, University of Bern;
  • Prof. Edwin Constable, Vice-Rector of Research and Talent Promotion, University of Basel;
  • Prof. Carlo Catapano, Director, IOR Institute of Oncology Research;
  • Prof. Boas Erez, Rector, Università della Svizzera Italiana;
  • Prof. Nicolas Fasel, Vice-Dean for Research and Innovation, Faculty of Biology and Medicine, University of Lausanne;
  • Prof. Susan Gasser, Director, Friedrich Miescher Institute for Biomedical Research (FMI);
  • Prof. Detlef Günther, Vice-President Research and Corporate Relations, ETH Zurich;
  • Prof. Denis Hochstrasser, Vice-Rector, University of Geneva, Head of Genetic and Laboratory Medicine Department, Geneva University Hospital (HUG);
  • Prof. Rolf Ingold, Vice-Rector for Research and Information Technology, University of Fribourg;
  • Dr Corinne Jud, Head of the Competence Division Method Development and Analytics, Agroscope;
  • Dr Caroline Kant, Executive Director, EspeRare Foundation Switzerland;
  • Prof. Jérôme Lacour, Dean, Faculty of Science, University of Geneva;
  • Prof. Jean-Marc Piveteau, President, Zurich University of Applied Sciences (ZHAW);
  • Prof. Alexandre Reymond, Director, Centre for Integrative Genomics (CIG), Faculty of Biology and Medicine, University of Lausanne;
  • Prof. Eduardo Sanchez, Dean, School of Business and Engineering Vaud (HEIG-VD), HES-SO;
  • Prof. Michael Schaepman, Vice-President for Veterinary Medicine and Natural Sciences, University of Zurich
  • Prof. Jürg Utzinger, Director, Swiss Tropical and Public Health Institute (Swiss TPH);
  • Mr Richard Walker, Chief Financial Officer and Secretary to the Board, Ludwig Institute for Cancer Research (LICR).

Co-opted Members

  • Dr Laurent Duret, CNRS Research Director, Laboratory of Biometry and Evolutionary Biology, Claude Bernard-Lyon 1 University, France.